Diyabetik Ayak


Şeker A., Değer G. U., Korkmaz T.

Diyabetik Ayak Klinik ve Radyolojik Değerlendirme Kesin Tanıya Giden Yol, Soheil Ashkani-Esfahani,Bedri Karaismailoglu,Siddhartha Sharma, Editör, Springer, London/Berlin , Singapore, ss.277-300, 2024

  • Yayın Türü: Kitapta Bölüm / Mesleki Kitap
  • Basım Tarihi: 2024
  • Yayınevi: Springer, London/Berlin 
  • Basıldığı Şehir: Singapore
  • Sayfa Sayıları: ss.277-300
  • Editörler: Soheil Ashkani-Esfahani,Bedri Karaismailoglu,Siddhartha Sharma, Editör
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

The number of diabetic patients is increasing, and it is estimated to reach 783,000,000

by 2045. In addition to acute metabolic problems, it can induce neuropathy and

vascular complications. These two complications are the important causes of dia-

betic foot problems. The International Working Group on the Diabetic Foot

(IWGDF) defines diabetic foot as having one or more of the following conditions:

peripheral neuropathy, peripheral artery disease, infection, ulcer(s), neuro-osteoarthropathy,

gangrene, and amputation [13].

Foot ulcer is defined as a wound extending to the dermis. It is one of the most

important diabetic complications, affecting 15–25% of the patients. Aside from

decreasing the quality of life, it increases morbidity and mortality. Unfortunately,

14–24% of these individuals will require lower-extremity amputations. Diabetes is

the major cause of amputations in the United States, accounting for 60–70% of all

amputations performed each year [4]. The complication rates after diabetes-related

amputations are also high. Local infections and soft tissue problems are seen in

9–59.3% of patients, with a reamputation risk of 16.5% in the first 3 months and

20–25% in the first year (Fig. 17.1) [57]. The mortality rates in diabetic amputees

are reported as 13–49% in the first year and 50–65.3% after 5 years [79].

Aside from their medical significance, diabetic foot problems raise healthcare

expenses. Over a 10-year period, the estimated costs of diabetic foot care and lower-extremity

amputations in the United States were $18 billion and $11.7 billion,

respectively [7, 10]. According to Kerr et al., the United Kingdom spent more than

£900 million on diabetic foot care in 2019 [11]. These findings highlight the signifi-

cance of diabetic foot care in both medical and economic implications. That’s why

a routine foot examination is advised for all diabetics.